Sensipar (cinacalcet) 30mg, 20 Tabs

Quick Overview
Cinacalcet, the generic form of Sensipar, is an effective and affordable medication commonly prescribed to treat hyperparathyroidism and high blood calcium levels.
  • Generic Medication
  • Prescription Required
  • 100% Money Back Guarantee
In stock
SKU
SENSIPAR30
$80.00
Cinacalcet, the generic form of Sensipar, is an effective and affordable medication commonly prescribed to treat hyperparathyroidism and high blood calcium levels. This condition is often associated with chronic kidney disease in patients undergoing dialysis. By regulating the levels of calcium and phosphorus in the body, Cinacalcet helps maintain the proper functioning of the parathyroid glands, kidneys, and bones, ultimately supporting overall health and well-being. Cinacalcet works by directly targeting the parathyroid glands and modulating the release of parathyroid hormone (PTH), which plays a vital role in regulating calcium and phosphorus levels in the blood. The medication effectively lowers PTH, calcium, and phosphorus levels, reducing the risk of complications such as cardiovascular disease and bone disorders in patients with chronic kidney disease. Cinacalcet offers a targeted approach to managing hyperparathyroidism and its associated symptoms, allowing patients to experience improved quality of life. When taking Cinacalcet, following your healthcare provider's instructions for proper dosage and administration is essential to ensure the medication's effectiveness and safety. As with any drug, potential side effects may occur, including nausea, vomiting, and dizziness. It is crucial to discuss any concerns or symptoms with your healthcare provider to address and manage any potential issues promptly. By adhering to your doctor's guidance and incorporating Cinacalcet into your treatment plan, you can successfully manage hyperparathyroidism and its associated complications, ultimately promoting better overall health.
More Information
ClassGENERIC
Low Pricesimple
Med Type Generic1
Rx Req1